ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 849 filers reported holding ISHARES TR in Q3 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,112,991 | -0.7% | 25,456 | +3.1% | 0.33% | -16.1% |
Q2 2023 | $3,136,015 | -0.7% | 24,701 | +1.0% | 0.40% | +16.1% |
Q1 2023 | $3,159,226 | +7.2% | 24,460 | +8.9% | 0.34% | +2.4% |
Q4 2022 | $2,948,318 | +23.9% | 22,457 | +10.3% | 0.33% | +26.5% |
Q3 2022 | $2,380,000 | +8.9% | 20,351 | +9.5% | 0.26% | +14.8% |
Q2 2022 | $2,186,000 | -7.0% | 18,582 | +3.1% | 0.23% | +4.1% |
Q1 2022 | $2,350,000 | -12.4% | 18,032 | +2.6% | 0.22% | -10.2% |
Q4 2021 | $2,683,000 | -9.5% | 17,576 | -4.2% | 0.25% | -11.5% |
Q3 2021 | $2,966,000 | -2.8% | 18,346 | -1.6% | 0.28% | -3.1% |
Q2 2021 | $3,053,000 | +5.7% | 18,653 | -2.7% | 0.29% | -4.7% |
Q1 2021 | $2,887,000 | -9.4% | 19,173 | -8.9% | 0.30% | -17.1% |
Q4 2020 | $3,187,000 | +15.6% | 21,040 | +3.4% | 0.36% | -3.5% |
Q3 2020 | $2,756,000 | +0.8% | 20,354 | +1.7% | 0.38% | -6.7% |
Q2 2020 | $2,734,000 | +22.9% | 20,004 | -3.1% | 0.40% | +3.6% |
Q1 2020 | $2,224,000 | +6850.0% | 20,646 | +7575.1% | 0.39% | +7680.0% |
Q4 2019 | $32,000 | – | 269 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |